Aspen has entered into an agreement with Novartis in terms of which it will acquire the rights to Mono-Embolex Read the full story

Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering. Read the full story

Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market. Read the full story

Iroko Pharmaceuticals signed a licensing agreement with Aspen Pharma for the exclusive rights to register and market ZORVOLEX (diclofenac) capsules in Australia and New Zealand. Read the full story

Aspen has entered big pharma deals with Merck and Co for an asset purchase agreement in which Aspen will by Merck's API business. Read the full story

A pharma partners contract worth $667 million was jointly awarded by South Africa to three big names in the pharma world, Aspen Pharmacare, Abbott Laboratories and Adcock Ingram, to supply life-prolonging HIV medicine to 12 international and domestic firms, to deal with its biggest health problem. Read the full story

Drug maker Cipla has entered in a pharma partners collaboartion with South Africa’s Aspen Pharmacare, a big pharma company to cater to the Australian market.

Read the full story

GlaxoSmithKline and  Aspen Pharmacare, both big pharma companies have inked new pharma deals wherein, GSK will sell 25 older brands marketed in Australia to South Africa's Aspen Pharmacare  for 172 million pounds ($270 million).

Read the full story

This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years Read the full story